We only have this paper's title and publication details.
Read it at the sourcePersonalized screening could become increasingly viable as costs for determining risk decrease.
No takes yet. Share an insight, caveat, or question.
Cenin et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: